Point-of-care pancreatic stone protein measurement in critically ill COVID-19 patients
Description
CONCLUSION: These first results suggest the potential advantages of monitoring PSP plasma levels through point-of-care technology, which could be useful in the absence of a specific COVID-19 biomarker. Additional data are needed to confirm these
